IFC Commits $12 Million Cornerstone Investment in Medela Potentia’s IPO to Strengthen Indonesia’s Healthcare Sector
- akhirnasution95
- 11 minutes ago
- 2 min read
As part of its ongoing efforts to boost the competitiveness of Indonesia’s healthcare distribution and manufacturing sectors, IFC has committed an equity investment of IDR 197 billion (approximately $12 million) as a cornerstone investor in the Initial Public Offering (IPO) of PT Medela Potentia Tbk (Medela Potentia). The company is a leading distributor of healthcare and pharmaceutical products, as well as a manufacturer of medical devices in Indonesia.
By participating in the IPO, IFC shows its support for companies leveraging capital markets to drive growth. The investment highlights how public listings can attract diverse sources of financing, encourage greater transparency, and support the strengthening of corporate governance through regulatory oversight. With untapped opportunities in Indonesia’s healthcare sector, capital markets can play an important role in mobilizing investment and advancing sector development.
The investment by IFC, a member of the World Bank Group and the largest global development institution focused on the private sector in emerging markets, will help Medela Potentia expand its reach in both domestic and regional markets, modernize its distribution infrastructure, and scale up its medical device production—supporting the Indonesian government’s strategic push to increase local manufacturing in the healthcare sector.
In line with national priorities to enhance health resilience and reduce reliance on imports, the Government of Indonesia has placed greater emphasis on the local production of essential medicines, medical supplies, and devices. Since May 2023, IFC has partnered with the Ministry of Health through the Indonesian Health Sector Growth Program to catalyze private sector investment and foster stronger public-private collaboration in the health sector.
Medela Potentia’s shares were officially listed on April 15 at the opening bell of the Indonesian Stock Exchange, with the company’s senior management, board members, and advisors in attendance.
"We are honored to have IFC’s support as we embark on this important milestone,” said Krestijanto Pandji, CEO of Medela Potentia. “This investment reinforces our commitment to expanding access to high-quality healthcare and pharmaceutical products and medical devices throughout Indonesia, while continuing to invest in technology, infrastructure, and innovation to meet the country’s growing healthcare needs.”
“IFC’s investment reflects our commitment to strengthening Indonesia’s healthcare system,” said Euan Marshall, IFC’s Country Manager for Indonesia and Timor-Leste. “We’re pleased to participate in Medela Potentia’s IPO, which demonstrates how capital markets can be leveraged to support companies that are advancing innovation and delivering long-term impact in critical sectors like healthcare.”
Through strategic partnerships like this, IFC aims to foster sustainable, inclusive growth and contribute to Indonesia’s broader development priorities, including improved health outcomes and deeper private sector engagement.